Kala Bio Analyst Price Targets - Benzinga

Kala Bio Inc

KALANASDAQ

Trade with Public

Trade with Public

$0.1730

0.00583.47%

Últ. Act.: Nov 3, 6:47 PM

Panorámica general Noticias Previsión de beneficios EventosPrecios objetivoFinanzas Sentimiento Propiedad Comparar Informe de acciones

Kala Bio Analyst Price Targets - Benzinga

Kala Bio Analyst Price Targets

Wall Street analyst price targets and consensus rating for Kala Bio (KALA).

Price Target Range — 7 Quarters

Analyst Consensus — 3 Analysts

2Buy

1Hold

Consensus RatingOutperform# Analysts3Avg. Consensus PT$1300Upside to Avg. PT+703744.1%

Rating Trend — Last 9 Months

Recent Analyst Actions

Ver todas las valoraciones →

Date	Firm	Analyst	Action	Rating Change	Price Target
Sep 29, 2025	HC Wainwright & Co.	Yi Chen	Downgrade	Buy→Neutral	—
Sep 17, 2025	HC Wainwright & Co.	Yi Chen	PT Raise	Buy	$600→$1750
Sep 11, 2025	Oppenheimer	Andreas Argyrides	PT Raise	Outperform	$750→$1650
Sep 8, 2025	Mizuho	Graig Suvannavejh	Initiate	Outperform	$1500
Jun 2, 2025	Oppenheimer	Andreas Argyrides	Assumes	Outperform	$750
May 23, 2025	HC Wainwright & Co.	Yi Chen	PT Cut	Buy	$750→$600
Apr 4, 2025	HC Wainwright & Co.	Yi Chen	Maintained	Buy	$750
Feb 13, 2025	HC Wainwright & Co.	Yi Chen	Maintained	Buy	$750
Nov 15, 2024	HC Wainwright & Co.	Yi Chen	Maintained	Buy	$750
Aug 19, 2024	Oppenheimer	Francois Brisebois	Maintained	Outperform	$750
May 17, 2024	HC Wainwright & Co.	Yi Chen	PT Cut	Buy	$1050→$900
Apr 2, 2024	HC Wainwright & Co.	Yi Chen	PT Cut	Buy	$1100→$1050
Apr 1, 2024	Oppenheimer	Francois Brisebois	Maintained	Outperform	$750
Nov 17, 2023	HC Wainwright & Co.	Yi Chen	PT Cut	Buy	$1200→$1100

Analyst Ratings News

PRO
HC Wainwright & Co. Maintains Buy on Kala Bio, Raises Price Target to $35

HC Wainwright & Co. analyst Yi Chen maintains Kala Bio (NASDAQ:KALA) with a Buy and raises the price target from $12 to $35.

Benzinga Newsdesk

PRO
Oppenheimer Maintains Outperform on Kala Bio, Raises Price Target to $33

Oppenheimer analyst Andreas Argyrides maintains Kala Bio (NASDAQ:KALA) with a Outperform and raises the price target from $15 to $33.

Benzinga Newsdesk

PRO
Mizuho Initiates Coverage On Kala Bio with Outperform Rating, Announces Price Target of $30

Mizuho analyst Graig Suvannavejh initiates coverage on Kala Bio (NASDAQ:KALA) with a Outperform rating and announces Price Target of $30.

Benzinga Newsdesk

This Harrow Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday

Avi Kapoor

PRO
Ladenburg Thalmann Initiates Coverage On Kala Bio with Buy Rating, Announces Price Target of $12

Ladenburg Thalmann analyst Aydin Huseynov initiates coverage on Kala Bio (NASDAQ:KALA) with a Buy rating and announces Price Target of $12.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Maintains Buy on Kala Bio, Lowers Price Target to $12

HC Wainwright & Co. analyst Yi Chen maintains Kala Bio (NASDAQ:KALA) with a Buy and lowers the price target from $15 to $12.

Benzinga Newsdesk